Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 79
Filter
Add more filters










Publication year range
1.
Placenta ; 27(6-7): 678-90, 2006.
Article in English | MEDLINE | ID: mdl-16122792

ABSTRACT

Influenza virus infection during pregnancy is implicated in one of the causes of premature delivery, abortion and stillbirth. Pro-inflammatory cytokines, such as interleukin (IL)-6 and tumor necrosis factor (TNF)-alpha produced by fetal membranes, are postulated to facilitate premature delivery. We investigated the secretion of IL-6 and TNF-alpha from primary cultured human fetal membrane chorion and amnion cells infected with influenza virus at protein and bioactivity levels in order to understand the pathology of premature delivery during influenza virus infection. Concentrations of IL-6 and TNF-alpha proteins were significantly increased in culture supernatants of chorion cells by influenza virus infection. Culture supernatants of the virus-infected chorion cells stimulated the proliferation of IL-6-sensitive 7-TD-1 cells and induced the cytolysis of TNF-alpha-sensitive L929 cells, both activities of which were inhibited by the addition of respective antibody, whereas no such phenomena were observed in amnion cells. The results demonstrated that only chorion cells secreted significant amounts of bioactive IL-6 and TNF-alpha proteins responding to influenza virus infection. The present study suggests a possibility that the secretion of bioactive IL-6 and TNF-alpha proteins from fetal membrane chorion cells is implicated in the pathogenesis of premature delivery during influenza virus infection.


Subject(s)
Chorion/virology , Influenza A virus/physiology , Influenza, Human/immunology , Interleukin-6/metabolism , Pregnancy Complications, Infectious/metabolism , Tumor Necrosis Factor-alpha/metabolism , Adult , Amnion/metabolism , Amnion/pathology , Amnion/virology , Apoptosis , Cell Proliferation/drug effects , Cells, Cultured/drug effects , Cells, Cultured/metabolism , Chorion/metabolism , Chorion/pathology , Culture Media, Conditioned/pharmacology , Enzyme-Linked Immunosorbent Assay , Female , Humans , Immunohistochemistry , Influenza, Human/metabolism , Pregnancy , Virus Replication
2.
Eur J Biochem ; 268(23): 6182-9, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11733013

ABSTRACT

Previously, we demonstrated apoptotic cell death in the chorion laeve trophoblast layer of human fetal membrane tissues during the late stages of pregnancy, the progression of apoptosis during incubation in vitro, and its suppression by a low concentration of glucocorticoid hormones. We now report examination of mRNA expression of inflammatory cytokines [interleukin (IL)-1beta, IL-6, tumor necrosis factor-alpha] and antioxidative enzyme genes [heme oxygenase 1, catalase, Mn-superoxide dismutase (SOD), Cu/Zn-SOD, glutathione S-transferase, glutathione reductase and glutathione peroxidase] and apoptosis-related genes during in vitro progression of apoptosis with or without glucocorticoid by a reverse transcription/PCR method. It was shown that the mRNA levels increased in chorion laeve tissue for each cytokine examined and for catalase, heme oxygenase 1 and Mn-SOD in direct correlation with the in vitro incubation period. By Western blotting the existence of Mn-SOD protein, and its slight increase with incubation time, was also shown. The investigation of the influence of antioxidative reagents [pyrrolidine dithiocarbamate (PDTC), N-acetyl-l-cysteine (NAC) and nordihydroguaiaretic acid (NDGA)] on DNA fragmentation showed that DNA fragmentation in chorion laeve tissues was inhibited by approximately 50% in the presence of 1 mm PDTC, 30 mm NAC and 1 mm NDGA. These results suggest that apoptotic cell death of the trophoblast layer of chorion tissues may be induced through intracellular oxidative stress at the stage of parturition.


Subject(s)
Antioxidants/pharmacology , Apoptosis/drug effects , Chorion/cytology , Chorion/drug effects , Trophoblasts/cytology , Trophoblasts/drug effects , Acetylcysteine/pharmacology , Apoptosis/genetics , Chorion/metabolism , DNA Fragmentation/drug effects , Female , Gene Expression/drug effects , Humans , In Vitro Techniques , Labor, Obstetric , Masoprocol/pharmacology , Oxidative Stress , Pregnancy , Pyrrolidines/pharmacology , RNA, Messenger/genetics , RNA, Messenger/metabolism , Superoxide Dismutase/genetics , Superoxide Dismutase/metabolism , Thiocarbamates/pharmacology , Trophoblasts/metabolism
3.
Biol Pharm Bull ; 24(4): 342-6, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11305592

ABSTRACT

In order to quantify fragmented DNA extracted from apoptotic cells, we devised a separation method which condenses fragmented DNA into a small band, separating it from larger-size DNA with agarose gel electrophoresis. Calf thymus DNA and standard fragmented DNA were loaded onto 1.0% gel for 0.5, 1.0, 1.5 and 2.0 cm length, and onto 0.7, 1.0, 1.5 and 2.0% of gels for 1 cm length. DNA was then extracted from gel slices with the UltraClean 15 DNA Purification Kit, and estimated by measuring fluorescence intensity using Hoechst No.33258 dye. DNA recovery from the gel showed constant values regardless of the amount of loaded DNA up to 1 microg/assay, and a plot of loaded DNA amounts vs. the DNA amount yielded resulted in a strait line in any gel concentration used. Our results show the best conditions to estimate DNA fragmentation rates in apoptotic cells in which fragmented DNA was separated from thymus DNA by loading on 1.0% gel for 1.0 cm length. We used our method to estimate fragmentation rates in DNA fractions extracted from apoptotic human cervical fibroblast, amnion epithelial and chorion laeve trophoblast cells by stimulation with actinomycin D. The results show that DNA fragmentation rates in these cells were consistent with the electrophoretic patterns of the DNA samples shown by their photographs.


Subject(s)
DNA Fragmentation , DNA/analysis , DNA/isolation & purification , Apoptosis , Cells, Cultured , Dactinomycin/pharmacology , Electrophoresis, Agar Gel , Epithelial Cells/chemistry , Epithelial Cells/drug effects , Extraembryonic Membranes/cytology , Extraembryonic Membranes/drug effects , Female , Fibroblasts , Humans , Nucleic Acid Synthesis Inhibitors/pharmacology , Pregnancy , Trophoblasts/chemistry , Trophoblasts/drug effects
4.
Anticancer Res ; 21(6A): 4083-6, 2001.
Article in English | MEDLINE | ID: mdl-11911296

ABSTRACT

Recurrent breast cancer has a very poor response rate to chemotherapy. To understand the degree of acquisition of multidrug resistance in recurrent disease, 24 recurrent breast tumors and 127 primary tumors were evaluated and compared for chemosensitivity in the histoculture drug response assay (HDRA). The evaluation rate was 98.8%. The HDRA utilizes 3-dimensional culture of human tumors on collagen-gel rafts. Doxorubicin (DXR), 5-fluorouracil (5-FU) and mitomycin C (MMC) were tested as standard agents and cisplatin (CDDP) as a candidate agent on surgical specimen of breast cancer in the HDRA. In vitro drug exposure in the HDRA was for 7 days. At the end of the assay, tumor response was assessed by the reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). The mean inhibition rates of primary tumors vs. recurrent tumors were 57.9% and 38.6% for DXR (p<0.0005); 59.9% and 42.8% for MMC (p<0.01); 49.0% and 33.4% for 5-FU (p<0.01); and 34.5% and 16.0% for CDDP (p<0.005), respectively. The recurrent cases were pretreated clinically with CAF (cyclophosphamide, DXR and 5-FU), CEF (cyclophosphamide, epirubicin and 5-FU) or CMF (cyclophosphamide, methotrexate and 5-FU). In the CAF and CEF group, the HDRA sensitivity to CDDP was significantly lower in recurrent disease (p<0.005) than that of primary breast cancer suggesting that one agent can induce resistance to another. This is further suggested by the fact that 64.7% of the recurrent cases were resistant to all 4 agents tested as opposed to 27% of the primary cases and that only 5.9% of the recurrent cases were sensitive to three or more agents as opposed to 18% of the primary cases. The correlation of the HDRA results to clinical outcome in the study was 80.0% with 15 cases evaluated consisting of 5 true positives, 3 false positives, 7 true negatives and no false negatives. Thus, the HDRA gives useful clinical information, in particular for the specific individualized treatment design necessary to overcome the multidrug resistance problem of recurrent breast cancer.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Breast Neoplasms, Male/drug therapy , Breast Neoplasms/drug therapy , Drug Resistance, Multiple , Neoplasm Recurrence, Local/drug therapy , Adult , Aged , Aged, 80 and over , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Breast Neoplasms/pathology , Breast Neoplasms, Male/pathology , Cyclophosphamide/administration & dosage , Doxorubicin/administration & dosage , Drug Resistance, Neoplasm , Drug Screening Assays, Antitumor , Epirubicin/administration & dosage , Female , Fluorouracil/administration & dosage , Humans , Male , Methotrexate/administration & dosage , Middle Aged , Neoplasm Staging
5.
J Neurosurg ; 95(2): 275-84, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11780898

ABSTRACT

OBJECT: There is growing evidence to indicate that tissue transplantation can potentially be a restorative neurosurgical treatment for patients with Parkinson disease (PD). In this study the authors investigated the clinical effect of unilateral intrastriatal grafting of autologous sympathetic neurons in patients with PD. METHODS: Four patients with PD who had been observed for 1 year after graft placement of autologous sympathetic neurons were selected for an analysis of the effect of that procedure. Sympathetic ganglion tissue was endoscopically excised from the thoracic sympathetic trunk and grafted into the unilateral caudate head and putamen of the PD patients. No changes were made in the patients' preoperative regimens of antiparkinsonian medications, and clinical evaluations were made principally according to those established by the Core Assessment Program for Intracerebral Transplantation Committee. Whereas the sympathetic neuron grafts failed to affect clinical scores reflecting the patients' motor performance, which was evaluated during either the "on" or "off' phases, the grafts significantly increased the duration of the levodopa-induced on period with consequent reduction in the percentage of time spent in the off phase. This beneficial effect may be explained by the results of the present in vitro experiment, which show that human sympathetic neurons have the ability to convert exogenous levodopa to dopamine and to store this synthesized dopamine. CONCLUSIONS: Sympathetic neuron autografts were found to improve performance status in patients with PD by reducing the time spent in the off phase. This clearly indicates that sympathetic ganglion tissue, the use of which involves few ethical issues, can be an efficacious donor source in cell transplantation therapy for PD. Further studies are needed to determine whether the grafts may provide long-lasting clinical benefits.


Subject(s)
Antiparkinson Agents/pharmacology , Antiparkinson Agents/therapeutic use , Ganglia, Sympathetic/transplantation , Levodopa/pharmacology , Levodopa/therapeutic use , Neurons/transplantation , Parkinson Disease/drug therapy , Parkinson Disease/surgery , Catecholamines/biosynthesis , Caudate Nucleus/surgery , Female , Follow-Up Studies , Ganglia, Sympathetic/drug effects , Ganglia, Sympathetic/physiopathology , Humans , In Vitro Techniques , Male , Middle Aged , Neurons/drug effects , Neurons/physiology , Parkinson Disease/physiopathology , Psychomotor Performance/drug effects , Psychomotor Performance/physiology , Putamen/surgery , Stereotaxic Techniques , Transplantation, Autologous , Treatment Outcome
6.
Chest ; 118(2): 384-90, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10936129

ABSTRACT

OBJECTIVE: We investigated the mechanism involved with the initial drop and subsequent recovery of exercise capacity in the early postoperative period of thoracotomy patients. METHODS: Sixteen patients (13 who had undergone lobectomy, 3 who had undergone pneumonectomy) underwent a routine pulmonary function test (PFT) and a cardiopulmonary exercise test preoperatively, within 14 postoperative days (POD; post-1; mean +/- SD, 9 +/- 2 POD), and after 14 POD (post-2; mean, 26 +/- 12 POD). RESULTS: After surgery on post-1, PFT results of FVC, FEV(1), and maximum ventilatory volume (MVV) significantly decreased. Oxygen uptake (VO(2)) at a venous blood lactate level of 2.2 mmol/L (La-2. 2), which was adopted as the empirical anaerobic threshold, and maximum V O(2) (VO(2)max) decreased significantly to 88.2 +/- 7.9% and 73.1 +/- 15.4% of the preoperative values, respectively. La-2.2 min ventilation (VE)/ MVV and maximum VEmax)/MVV increased significantly from 0.36 +/- 0.08 to 0. 66 +/- 0.20 and from 0.58 +/- 0.14 to 0.80 +/- 0.09, respectively. On post-2, though La-2.2 VO(2) did not change, VO(2)max improved significantly to 81.5 +/- 19.7% of the preoperative values, in association with significant increases in maximal tidal volume and VEmax, which were produced by significant increases in the PFT results. La-2.2 VE/MVV also decreased significantly to 0.49 +/- 0.13, which indicated a sufficient recovery of respiratory reserve at submaximal exercise. CONCLUSIONS: The initial drop of exercise capacity after lung resection seems to be derived from both circulatory and ventilatory limitations. Further, the subsequent recovery within 1 month seems to be produced by an improvement in ventilatory limitation, which was caused by the surgical injury to the chest wall.


Subject(s)
Adaptation, Physiological/physiology , Exercise Tolerance/physiology , Lung Diseases/physiopathology , Recovery of Function/physiology , Thoracotomy , Aged , Aged, 80 and over , Exercise Test , Female , Follow-Up Studies , Humans , Lung Diseases/surgery , Male , Middle Aged , Pneumonectomy , Postoperative Period , Respiratory Function Tests
7.
Mod Pathol ; 13(7): 736-41, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10912932

ABSTRACT

Immunohistochemical expressions of type 1 blood group antigens were studied for 95 cases of thyroid tumors, including 29 follicular adenomas, 23 follicular carcinomas, and 43 papillary carcinomas, applying monoclonal antibodies against DU-PAN-2, CA19-9, Lewis(a) (Le(a)), and Lewis(b) (Le(b)). Normal thyroid tissue invariably failed to express all four antigens. In follicular adenomas, DU-PAN-2 and CA19-9 were focally expressed in 7% and 21% of cases, and in follicular carcinomas, CA19-9 expression was limited to one case (4%); all cases were negative for DU-PAN-2. No or little expression of Le(a) or Le(b) was observed in these follicular tumors. In contrast, DU-PAN-2, CA19-9, Le(a), and Le(b) were expressed in 98%, 84%, 33%, and 49% of 43 papillary carcinomas, respectively. The positive stainings were observed mainly on the luminal surface of the tumor cells. The number of tumor cells that expressed DU-PAN-2 generally was greater than that of tumor cells that expressed CA19-9, Le(a), or Le(b). There was no significant difference in antigen expressions in female papillary carcinomas between subjects who were younger and older than 50 years old. The results suggest that DU-PAN-2 would be a useful immunohistochemical marker for distinguishing papillary carcinomas from follicular tumors. These immunohistochemical profiles imply the following: the activity of alpha2-3 sialyltransferase, a specific glycosyltransferase, would be more strongly enhanced in papillary carcinomas than in follicular tumors; the antigen expressions in papillary carcinomas may not be related to the alteration of the female sex hormone environment.


Subject(s)
Antigens, Neoplasm/biosynthesis , Biomarkers, Tumor/metabolism , CA-19-9 Antigen/biosynthesis , Carcinoma, Papillary/metabolism , Thyroid Neoplasms/metabolism , Adenocarcinoma, Follicular/metabolism , Adenocarcinoma, Follicular/pathology , Adenoma/metabolism , Adenoma/pathology , Adult , Aged , Aged, 80 and over , Carcinoma, Papillary/pathology , Female , Fluorescent Antibody Technique, Indirect , Humans , Male , Middle Aged , Thyroid Neoplasms/pathology , Thyroiditis, Autoimmune/metabolism , Thyroiditis, Autoimmune/pathology
8.
Gan To Kagaku Ryoho ; 27(5): 717-22, 2000 May.
Article in Japanese | MEDLINE | ID: mdl-10832440

ABSTRACT

We examined the chemosensitivity of non-small cell lung cancer (NSCLC) tissues to CDDP, 5-FU, ADM, MMC, ETP and SN38 using histoculture drug response assay (HDRA). One-hundred and thirty surgical specimens from NSCLC patients who were not given preoperative chemotherapy were used. The inhibition indexes of CDDP, 5-FU, MMC, ADM, ETP and SN38 were 39.1 +/- 18.2%, 48.0 +/- 19.7%, 63.3 +/- 17.7%, 47.6 +/- 22.0%, 36.9 +/- 21.1%, and 37.9 +/- 25.2%, respectively. Inhibition indexes were above the cutoff level, i.e., 'judged sensitive,' in 40 cases (31.3%) for CDDP, 34 cases (27.4%) for 5-FU, 54 cases (44.3%) for MMC, 36 cases (33.0%) for ADM, 29 cases (29.8%) for ETP, and 34 cases (37.4%) for SN38, respectively. In almost one-third of patients, the inhibition indexes of all drugs were under cutoff levels. Correlations between in vitro chemosensitivity data and patient responses to chemotherapy were obtained from 16 evaluable patients, and a 44.4% true positive rate and a 100% true negative rate were observed. Our results with HDRA for NSCLC showed a high incidence of intrinsic multidrug resistance. HDRA may help doctors to avoid non-effective chemotherapy for NSCLC patients.


Subject(s)
Antineoplastic Agents/pharmacology , Carcinoma, Non-Small-Cell Lung/pathology , Lung Neoplasms/pathology , Adenocarcinoma/pathology , Adult , Aged , Aged, 80 and over , Camptothecin/analogs & derivatives , Camptothecin/pharmacology , Carcinoma, Squamous Cell/pathology , Cisplatin/pharmacology , Doxorubicin/pharmacology , Drug Screening Assays, Antitumor , Etoposide/pharmacology , Female , Fluorouracil/pharmacology , Humans , Irinotecan , Male , Middle Aged , Mitomycin/pharmacology , Tumor Cells, Cultured
9.
Cancer Detect Prev ; 24(1): 61-71, 2000.
Article in English | MEDLINE | ID: mdl-10757124

ABSTRACT

We investigated biosynthesis of Vicia graminea lectin (VGA)- and Vicia unijuga lectin (VUA)-binding (Vgu) glycoproteins, which are human malignant tumor-associated antigens, in cultured human tumor and non-tumor cells by pulse-labeling experiments with [35S]-methionine, followed by immunoprecipitation using immobilized VUA, SDS-PAGE and autofluorography. It was shown that Vgu glycoproteins synthesized by tumor cells were 15-30 times greater than those of non-tumor cells. It was also shown that about 40-70% of Vgu glycoproteins synthesized by non-tumor cells were secreted from the cells while more than 80% of the antigen synthesized by tumor cells was not secreted, and that Vgu glycoproteins consisted of multiple molecular species with the same epitope. To estimate the epitope structure of Vgu glycoproteins, in preliminary experiments we prepared sialoglycoproteins and/or sialoglycopeptides from purified human glycophorin A. Human glycophorins A(M) and A(N) (GPs-A(M) and A(N)) were treated with Clostridium perfringens neuraminidase to remove all sialic acid residues linked to carbohydrate chains, with Newcastle disease virus (NDV) to remove alpha2-3 linked sialic acid residues, and by Edman's degradation to eliminate N-terminal amino acid of GP-As. Partial or complete desialylation reactions resulted in disappearance of the reactivity of GP-A(M) and GP-A(N) with corresponding antisera and in appearance of reactivities with VUA and VGA. Elimination of N-terminal amino acid of GP-As also resulted in appearance of reactivities with VUA. These results show that sialoglycoproteins with similar serological properties of Vgu glycoprotein could be prepared from GP-As, and suggest that the epitope structure of Vgu glycoprotein may be related to the MN blood type-epitope structure and its sialic acid residues at N-terminal moiety of GP-As.


Subject(s)
Amnion/metabolism , Antigens, Tumor-Associated, Carbohydrate/biosynthesis , Chorion/metabolism , Epitopes/analysis , Glycoproteins/biosynthesis , Lectins/metabolism , Neoplasms/metabolism , Plant Lectins , Amnion/cytology , Cells, Cultured , Chorion/cytology , Electrophoresis, Polyacrylamide Gel , Female , Hemagglutination Inhibition Tests , Humans , Neoplasms/pathology , Precipitin Tests
10.
J Biol Chem ; 275(11): 7451-4, 2000 Mar 17.
Article in English | MEDLINE | ID: mdl-10713044

ABSTRACT

Human RAD9 protein (hRAD9) is a homolog of the fission yeast Rad9 protein, one of the six so-called checkpoint Rad proteins involved in the early steps of DNA damage checkpoint response in Schizosaccharomyces pombe. It has been shown previously that, in vivo, a highly modified form of hRAD9 makes a ternary complex with two other checkpoint Rad proteins, hRAD1 and hHUS1 (Volkmer, E., and Karnitz, L. M. (1999) J. Biol. Chem. 274, 567-570; St. Onge, R. P., Udell, C. M., Casselman, R., and Davey, S. (1999) Mol. Biol. Cell. 10, 1985-1995). However, the function of this complex is not known at present. To help define the functions of checkpoint Rad proteins in humans, we expressed hRAD9 in Escherichia coli, purified the recombinant protein and characterized it. We found that hRAD9 is a 3' to 5' exonuclease and located the nuclease active site to the region between residues 51 and 91 of the 391-amino acid-long protein. Our results suggest that exonucleolytic processing of primary DNA lesion by hRAD9 may contribute to DNA damage checkpoint response in humans.


Subject(s)
Cell Cycle Proteins/metabolism , Exodeoxyribonucleases/metabolism , Nuclear Proteins/metabolism , Cell Cycle Proteins/genetics , Cell Nucleus/enzymology , DNA Repair , Exodeoxyribonuclease V , Exodeoxyribonucleases/genetics , Humans , Nuclear Proteins/genetics , Recombinant Proteins/metabolism , Signal Transduction , Substrate Specificity
11.
Mol Cell Biol ; 20(7): 2446-54, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10713168

ABSTRACT

DNA interstrand cross-links are induced by many carcinogens and anticancer drugs. It was previously shown that mammalian DNA excision repair nuclease makes dual incisions 5' to the cross-linked base of a psoralen cross-link, generating a gap of 22 to 28 nucleotides adjacent to the cross-link. We wished to find the fates of the gap and the cross-link in this complex structure under conditions conducive to repair synthesis, using cell extracts from wild-type and cross-linker-sensitive mutant cell lines. We found that the extracts from both types of strains filled in the gap but were severely defective in ligating the resulting nick and incapable of removing the cross-link. The net result was a futile damage-induced DNA synthesis which converted a gap into a nick without removing the damage. In addition, in this study, we showed that the structure-specific endonuclease, the XPF-ERCC1 heterodimer, acted as a 3'-to-5' exonuclease on cross-linked DNA in the presence of RPA. Collectively, these observations shed some light on the cellular processing of DNA cross-links and reveal that cross-links induce a futile DNA synthesis cycle that may constitute a signal for specific cellular responses to cross-linked DNA.


Subject(s)
DNA Repair/genetics , DNA/biosynthesis , Animals , CHO Cells , Cricetinae , Cross-Linking Reagents , DNA-Binding Proteins/metabolism , Endonucleases/metabolism , Ficusin/metabolism , Humans , Malondialdehyde/metabolism , Molecular Structure , Proteins/metabolism , Replication Protein A
12.
Int J Biol Markers ; 14(2): 99-105, 1999.
Article in English | MEDLINE | ID: mdl-10399629

ABSTRACT

Determination of the standard elimination kinetics of tumor markers will be helpful in the diagnosis of malignancies. We analyzed the disappearance curves for serum tumor marker levels after resection of intrathoracic malignancies. Serum levels of CEA, SLX, AFP, CA 19-9, SCC, TPA and CYFRA were measured several times after surgery in a total of 40 patients. To obtain precise biological half-lives, we applied non-linear least square analysis, taking into consideration the possibility of residual tumor cells. Disappearance curves were monophasic for CEA, SCC, TPA, CYFRA and SLX and biphasic for CA 19-9 and AFP. Temporary elevation of serum levels after surgery was observed for SCC, TPA and CYFRA. The average half-lives of CEA, SLX, SCC, TPA and CYFRA were 1.5 days, 2.7 days, 2.2 hours, 2.5 hours and 1.5 hours, respectively. The average half-life of CA 19-9 was 0.5 days in the first compartment and 4.3 days in the second compartment, while that of AFP was 1.0 days and 6.3 days, respectively. These values will be helpful in the interpretation of serum tumor marker levels after surgery.


Subject(s)
Biomarkers, Tumor/blood , Serpins , Thoracic Neoplasms/surgery , Adult , Aged , Aged, 80 and over , Antigens, Neoplasm/blood , CA-19-9 Antigen/blood , Carcinoembryonic Antigen/blood , Female , Humans , Keratin-19 , Keratins , Lewis Blood Group Antigens , Lewis X Antigen/blood , Male , Middle Aged , Oligosaccharides/blood , Sialyl Lewis X Antigen , Thoracic Neoplasms/mortality , Tissue Polypeptide Antigen/blood
13.
Hum Reprod ; 14(5): 1324-7, 1999 May.
Article in English | MEDLINE | ID: mdl-10325286

ABSTRACT

Here we report the first case of prenatally diagnosed fetal renal mesoblastic nephroma occurring after transfer of a cryopreserved embryo. A 37 year old woman, having immunological infertility, was treated by in-vitro fertilization (IVF) and embryo transfer. Following unsuccessful IVF using fresh embryos, the patient conceived after transfer of cryopreserved-thawed embryos. The chromosomal analysis identified a normal karyotype at 16 weeks' gestation when amniocentesis was performed. The pregnancy course was uneventful until 28 weeks' gestation when polyhydramnios associated with fetal renal tumour was detected using ultrasonography. A male infant weighing 2564 g was born via Caesarean section at 34 weeks' gestation. A left nephrectomy was performed 5 days after delivery and the tumour was identified histologically as a mesoblastic nephroma. The postoperative course was uncomplicated to this point.


Subject(s)
Cryopreservation , Embryo Transfer , Fertilization in Vitro , Kidney Neoplasms/diagnostic imaging , Nephroma, Mesoblastic/diagnostic imaging , Ultrasonography, Prenatal , Adult , Female , Humans , Karyotyping , Kidney Neoplasms/congenital , Male , Nephroma, Mesoblastic/congenital , Pregnancy
14.
Prenat Diagn ; 19(1): 21-4, 1999 Jan.
Article in English | MEDLINE | ID: mdl-10073901

ABSTRACT

Thanatophoric dysplasia (TD) is the most frequent form of neonatal lethal skeletal dysplasia. Recently. mutations in the fibroblast growth factor receptor 3 (FGFR3) gene that cause two subtypes of this disorder, type I (TDI) and type II (TDII), have been identified. This discovery has now made it possible to make a definite diagnosis of TD by molecular methods. To date, prenatal diagnosis of TD has been accomplished by ultrasonography in the second trimester. However, it is not always possible to distinguish TD fetuses it utero from the other osteochondrodysplasias by ultrasonography or radiography. We report on the prenatal diagnosis of a TD fetus, showing severe shortness of limbs and polyhydramnios, by identification of a mutation in the FGFR3 gene. Genomic DNA was isolated from the amniotic fluid and then subjected to PCR amplification. The common TDI mutation, C-->T transition at nucleotide 742 in the FGFR3 gene, was identified using restriction enzyme analysis. This information was critical in obstetric management decisions later in pregnancy. However, although the mutation responsible for TDI was detected previously, we noticed some inconsistencies in the published PCR results and have proposed a correction.


Subject(s)
DNA Mutational Analysis , Polymerase Chain Reaction , Prenatal Diagnosis , Receptors, Fibroblast Growth Factor/genetics , Thanatophoric Dysplasia/diagnosis , Thanatophoric Dysplasia/genetics , Adult , Amniocentesis , Fatal Outcome , Female , Gestational Age , Humans , Male , Pregnancy , Ultrasonography, Prenatal
15.
Nucleic Acids Res ; 27(4): 979-83, 1999 Feb 15.
Article in English | MEDLINE | ID: mdl-9927729

ABSTRACT

An ionizing radiation-induced DNA lesion, thymine glycol, is removed from DNA by a thymine glycol DNA glycosylase with an apurinic/apyrimidinic (AP) lyase activity encoded by the Escherichia coli endonuclease III ( nth ) gene and its homolog in humans. Cells from Cockayne syndrome patients with mutations in the XPG gene show approximately 2-fold reduced global repair of thymine glycol. Hence, I decided to investigate the molecular mechanism of the effect of XPG protein observed in vivo on thymine glycol removal by studying the interactions of XPG protein and human endonuclease III (HsNTH) protein in vitro and the effect of XPG protein on the activity of HsNTH protein on a substrate containing thymine glycol. The XPG protein stimulates the binding of HsNTH protein to its substrate and increases its glycosylase/AP lyase activity by a factor of approximately 2 through direct interaction between the two proteins. These results provide in vitro evidence for a second function of XPG protein in DNA repair and a mechanistic basis for its stimulatory activity on HsNTH protein.


Subject(s)
DNA Repair , DNA-Binding Proteins/metabolism , Endodeoxyribonucleases/metabolism , Endonucleases/metabolism , Escherichia coli Proteins , DNA/metabolism , Deoxyribonuclease (Pyrimidine Dimer) , Endodeoxyribonucleases/genetics , Humans , Nuclear Proteins , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Substrate Specificity , Transcription Factors
16.
Cancer Res ; 58(22): 5196-200, 1998 Nov 15.
Article in English | MEDLINE | ID: mdl-9823332

ABSTRACT

The nucleotide-excision repair (NER) system removes bulky DNA adducts and is thought to be involved in resistance to chemotherapeutic drugs, which act by damaging DNA. In this study, we have investigated the ability of the NER system to recognize and excise melphalan monoadducts from a 140-mer DNA substrate. We show that rodent and human cell-free extracts (CFEs) excise 26-29-nt-long oligomers from a synthetic 140-mer containing centrally located melphalan adducts. CFEs from cell lines with mutations in xeroderma pigmentosum group F or G genes did not excise these alkylated oligomers; however, mixing the two CFEs restored excision activity to the level found with wild-type CFEs. These results demonstrate the ability of the NER system to excise melphalan monoadducts, and are consistent with the hypothesis that NER may be involved in resistance to melphalan chemotherapy.


Subject(s)
Antineoplastic Agents, Alkylating/metabolism , DNA Adducts/metabolism , DNA Repair , Alkylation , Animals , CHO Cells , Cell-Free System , Cricetinae , DNA/metabolism , Drug Resistance , HeLa Cells , Humans
17.
Biol Pharm Bull ; 21(10): 1024-9, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9821804

ABSTRACT

In the trophoblast layer of the chorion laeve of human fetal membranes obtained by cesarean section at the month of normal parturition, cells with condensed nuclei could be observed by histochemical examination. Incubating fetal membranes at 37 degrees C in vitro in cultivation medium, the frequency of cells with condensed nuclei increased in the chorion laeve, associating with an increase in DNA fragmentation and the population of in situ TUNEL (terminal deoxynucleotidyl transferase (TdT)-mediated dUTP-X nick end labeling) staining-positive cells. The progressed apoptotic cell death in the chorion laeve in vitro was suppressed by incubation of the tissue in the presence of glucocorticoids, cortisone or hydrocortisone, which was also demonstrated by DNA fragmentation analysis and in situ TUNEL staining. These results reveal that a substantial proportion of trophoblast cells in the chorion laeve of human fetal membranes are induced to undergo apoptosis at the end of pregnancy, and that the apoptosis progresses rapidly in vitro as the incubation period increases. It is suggested that certain hormones such as glucocorticoid, may be related to the regulation of the apoptosis in human fetal membranes.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Apoptosis/drug effects , Apoptosis/physiology , Chorion/cytology , Chorion/drug effects , Cortisone/pharmacology , Hydrocortisone/pharmacology , Amnion/cytology , Amnion/drug effects , Amnion/metabolism , Chorion/metabolism , DNA/analysis , DNA/metabolism , Female , Humans , Immunohistochemistry , In Situ Nick-End Labeling , Pregnancy
18.
Kyobu Geka ; 51(11): 944-8, 1998 Oct.
Article in Japanese | MEDLINE | ID: mdl-9789425

ABSTRACT

From January 1986 to May 1998, 45 lung cancer patients with chest wall invasion (P3) underwent resection (40 male, 5 female), (median age 63.2 yrs (30-79)). Histological types were squamous cell carcinoma in 20, adenocarcinoma in 14, large cell carcinoma in 7, adenosquamous cell carcinoma in 2, and unknown in 2. Operative methods of lung resection were total pneumonectomy in 2, bilobectomy in 3, lobectomy in 38, and partial lung resection in 2. Resection was regarded as complete in 35 and incomplete in 10 patients. Thirty one patients had negative lymph nodes (N0), 9 had peribronchial or hilar lymph node metastases (N1), and 5 had mediastinal lymph node metastases (N2). The extent of tumor invasion to chest wall was P3a (invasion within parietal pleura) in 11, P3b-c (invasion to intercostal muscle) in 16, P3d (invasion to rib) in 18, patients. 5-year survival rate was totally 19.7%. Cisplatin based chemotherapy and concurrent thoracic radiation following surgery (CCRT) was performed in latest nine P3d cases. Partial response was observed in 5 of 9 cases (response rate 56%) and viable tumor cell in the primary site was not seen histologically in 5 of 9 cases. Three year survival rate was 46.9% for CCRT(+) 11.1% for CCRT(-). Acturial 5-year survival rate in P3a-d was 19.76%. P3d cases had poor survival, but CCRT improved prognosis of P3d cases.


Subject(s)
Lung Neoplasms/pathology , Lung Neoplasms/therapy , Pneumonectomy , Thoracic Neoplasms/pathology , Adult , Aged , Chemotherapy, Adjuvant , Female , Humans , Lung Neoplasms/mortality , Male , Middle Aged , Neoplasm Invasiveness , Preoperative Care , Radiotherapy, Adjuvant , Survival Rate , Thoracic Surgical Procedures , Treatment Outcome
19.
J Biomech ; 31(6): 545-54, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9755039

ABSTRACT

Static relations between elbow joint angle and torque at constant muscle activity in normal volunteers were investigated with the aid of an artificial neural network technique. A subject sat on a chair and moved his upper- and forearm in a horizontal plane at the height of his shoulder. The subject was instructed to maintain the elbow joint at a pre-determined angle. The wrist was then pulled to extend the elbow joint by the gravitational force of a weight hanging from a pulley. Integrated electromyograms (IEMGs), elbow and shoulder joint angles and elbow joint torque were measured. Then the relation among IEMGs, joint angles and torque was modeled with the aid of the artificial neural network, where IEMGs and joint angles were the inputs and torque was the output. After back propagation learning, we presented various combinations of IEMGs, shoulder and elbow joint angles to the model and estimated the elbow joint torque to obtain the torque-angle relation for constant muscle activation. The elbow joint torque increased and then decreased with extension of the elbow joint. This suggests that if the forearm is displaced from an equilibrium point, the torque angle relation would not act like a simple spring. In a view of the musculoskeletal structure of the elbow joint, the relation between the elbow joint angle and the moment arm of the elbow flexor muscles seems to have a dominant effect on the torque-angle relation.


Subject(s)
Elbow Joint/physiology , Adult , Arm/physiology , Electromyography , Forearm/physiology , Humans , Male , Models, Biological , Muscle, Skeletal/physiology , Neural Networks, Computer , Torque
20.
Int J Biochem Cell Biol ; 30(5): 609-22, 1998 May.
Article in English | MEDLINE | ID: mdl-9693961

ABSTRACT

We have previously reported that Vicia graminea lectin (VGA)- and Vicia unijuga lectin (VUA)-binding glycoproteins (Vgu glycoproteins), malignant tumor-associated antigens, exist in human meconium and amniotic fluid. To examine the origin of Vgu glycoprotein, their presence, some of their chemical and serological properties and their biosynthesis in the human fetal membrane, amnion and chorion laeve and accompanying membrane cells were examined. Perchloric acid-soluble fractions were prepared from human amnion and chorion laeve, after which VUA-binding components (Vgu glycoproteins) were separated by HPLC and affinity chromatography using immobilized VUA. Biosynthesis of the antigens in primary cultured cells prepared from the amnion and chorion laeve were examined by pulse-labeling and immunoprecipitation using immobilized VUA and compared with those in cultured human cancer cells. The results indicated that the serological properties of VUA-binding components in fetal membranes were similar to those of meconium and amniotic fluid, that many molecular species of VUA-binding components were synthesized in amnion and chorion laeve cells and that about 40-50% of antigens synthesized are secreted from cells while antigens synthesized in cultured cancer cells human were hardly secreted with more than 95% of the antigens remaining in the cells. From these results, we concluded that a large part of Vgu glycoproteins found in amniotic fluid is synthesized in cells of the amnion and chorion laeve and secreted into the fluid, and that Vgu glycoproteins synthesized in cancer cells were not secreted, rather they were retained in the cells.


Subject(s)
Antigens, Tumor-Associated, Carbohydrate/metabolism , Glycoproteins/metabolism , Lectins/metabolism , Plant Lectins , Amnion/cytology , Amnion/metabolism , Cells, Cultured , Chorion/cytology , Chorion/metabolism , Glycoproteins/biosynthesis , Humans , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...